Document Detail

Early assessment of the severity of asphyxia in term newborns using parameters of blood count.
Jump to Full Text
MedLine Citation:
PMID:  21218117     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Acute perinatal asphyxia is a major cause of death and neurological injury in newborn infants. Severe asphyxia can occur in infants around the time of birth for several reasons. The aim of our study was to find the most sensitive, easily obtainable and fast assessable parameter of the presence and quantification of asphyxia.In our study 39 term newborns (15 healthy term newborns and 24 asphyxial term newborns), from vaginal deliveries admitted within 24 hours of life were monitored and parameters of blood count from venous blood were assessed. Laboratory findings of blood count parameters revealed significant differences between term asphyxial and healthy newborns in erythrocyte count and hemoglobin and hematocrit values.Hematological changes observed early after delivery can determine the duration of hypoxemia (acute vs. chronic) and asphyxia of short duration may be accompanied without occurrence of polyglobulia.
Ingrid Brucknerová; Eduard Ujházy; Michal Dubovický; Mojmír Mach
Related Documents :
2178457 - Anemia of prematurity: progress and prospects.
21234187 - Sudden cardiac death in children and adolescents (excluding sudden infant death syndrome).
3031977 - Low incidence of acquired cytomegalovirus infection in neonates transfused with washed ...
3505617 - Sudden death following white cell transfusion in a premature infant.
18635477 - An evaluation of a new combined spo2/ptcco2 sensor in very low birth weight infants.
21575317 - Evaluation of glomerular and tubular renal function in neonates with birth asphyxia.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Interdisciplinary toxicology     Volume:  1     ISSN:  1337-6853     ISO Abbreviation:  Interdiscip Toxicol     Publication Date:  2008 Dec 
Date Detail:
Created Date:  2011-01-10     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  101528175     Medline TA:  Interdiscip Toxicol     Country:  Slovakia    
Other Details:
Languages:  eng     Pagination:  211-3     Citation Subset:  -    
1 Pediatric Hospital, School of Medicine, Comenius University, Bratislava, Slovak Republic.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): Interdiscip Toxicol
Journal ID (publisher-id): ITX
ISSN: 1337-6853
ISSN: 1337-9569
Publisher: Slovak Toxicology Society SETOX
Article Information
Download PDF
Copyright © 2010 Slovak Toxicology Society SETOX
Received Day: 21 Month: 9 Year: 2008
Revision Received Day: 10 Month: 10 Year: 2008
Accepted Day: 15 Month: 10 Year: 2008
Print publication date: Month: 12 Year: 2008
Electronic publication date: Month: 11 Year: 2010
Volume: 1 Issue: 3-4
First Page: 211 Last Page: 213
ID: 2994022
PubMed Id: 21218117
Publisher Id: ITX-1-211
DOI: 10.2478/v10102-010-0043-x

Early assessment of the severity of asphyxia in term newborns using parameters of blood count
Ingrid Brucknerová1
Eduard Ujházy2
Michal Dubovický2
Mojmír Mach2
11st Pediatric Hospital, School of Medicine, Comenius University, Bratislava, Slovak Republic
2Institute of Experimental Pharmacology, Slovak Academy of Sciences, Bratislava, Slovak Republic
Correspondence: Correspondence address: Ingrid Brucknerová, MD., PhD. 1st Pediatric Hospital, School of Medicine, Comenius University, Limbová 1, 833 40 Bratislava, Slovak Republic. E-MAIL:


The fetal tissues, which are adapted to a low oxygenation during intrauterine development, are subjected to a rapid change in an oxygen concentration after delivery. Birth itself is a strong oxidative stress. Oxidative stress, excess of free radicals and their reactive metabolites in the organism, plays an important role in the pathogenesis of so called free-radical diseases, not only in adults but also in newborns (Brucknerová et al., 2007; Tsukahara, 2007). In the case of preterm newborns the consequences of asphyxia are even more threatening due to the immaturity of enzymatic and non-enzymatic antioxidant mechanisms. Postasphyxial complications have a broad spectrum (Brucknerová & Benedeková, 2000; Brucknerová et al., 2005).

Changes in the hemopoietic system can be observed as complications of asphyxia. Altered biophysical characteristics of blood, e.g. changes in the structure and function of erythrocytes, leukocytes and thrombocytes can be caused be asphyxia (Curtin et al., 2002; Bracci et al., 2006).

Hematologic adaptations in the fetus include long- and short-term mechanisms (Rolfo et al., 2007). Polycythemia is not only a consequence of intrauterine growth retardation, but may be caused also by asphyxia. During chronic hypoxemia, polycythemia is developed as an adaptation to lack of oxygen supply. Due to decreased tissue oxygenation, increased production of erythropoietin by the kidney is followed by an increasing number of erythrocytes and raised fetal blood volume. If hypoxemia is present also during labor, hemoconcentration develops. Polycythemia/hemoconcentration changes blood biophysical characteristics, with elevated values of blood viscosity. Hyperviscosity has a negative influence on the postnatal newborn's adaptation and affects blood distribution between organs. The higher the viscosity, the lower the blood flow in the organism (central nervous system, cardiovascular, respiratory or urinary system), and the higher the risk of thrombosis, mainly in the CNS, increased minute volume and increased right-to-left shunt. On the other hand, acute hypoxemia involves short-term responses like reduction of body temperature, reduction of heart rate and/or redistribution of circulation (Singer, 1999). Hematological changes observed early after delivery can determine the duration of hypoxemia (acute vs. chronic) and help to assess therapeutic strategy.

Patients and methods

The study involved 39 term newborns (15 healthy term newborns, HTN, birth weight 3675±765 g and 24 asphyxial term newborns, ATN, birth weight 2752±144.5 g), from vaginal deliveries admitted within 24 hours of life. In both groups of newborns, blood samples of venous blood were taken on the 1st and 5th day of life and parameters of blood count (erythrocytes, hemoglobin, hematocrit, leukocytes, and thrombocytes) were determined.

Blood count was determined by an automatic analyzer ADVIA 120 (Bayer Diagnostics, New York, USA) using an optical system for measurement. The number of erythrocytes, leukocytes and thrombocytes was assessed by the analyzer using a laser beam which registered the flow of cells in certain time intervals. Hemoglobin was measured colorimetrically. Using a laser beam, the size of erythrocytes was determined and further the value of hematocrit was calculated.

For statistical analysis ANOVA followed by Fisher's post hoc test was used, p ≤ 0.05 was considered significant. The presence of asphyxia was the first factor (asphyxial term newborns, healthy term newborns) and the time of blood sampling was the second factor (1st and 5th day of life).

This study complies with the guidelines for human studies and animal welfare regulations and subjects have given their informed consent. The study protocol has been approved by the Committee on Human Research in Medical School, Comenius University, Bratislava, Slovakia.


Laboratory findings of blood count parameters revealed significant differences between term asphyxial and healthy newborns in erythrocyte count and hemoglobin and hematocrit values (Table 1). We did not observe any differences between these groups in leukocyte and thrombocyte counts.


Several changes in structure, function and amount of certain blood elements have been observed in asphyxia (Curtin et al., 2002; Bracci et al., 2006).

In the asphyxia, the increased production of erythropoietin increases the amount of nucleated erythrocytes, from which the non-nucleated cells matured gradually. The presence of nucleated erythrocytes in umbilical blood confirms the presence of an asphyxial event during intrauterine development (Curtin et al., 2002; Bracci et al., 2006). An increased amount of nucleated erythrocytes is the consequence of chronic intrauterine asphyxia (Phelan et al., 1995; Fahnenstich et al., 1995).

However in acute asphyxia, another physiological adaptation mechanism is present. This mechanism, activated by asphyxia, consists in shunting blood from the skin and splanchnic area to the heart, adrenals, and brain. This recirculation of blood ostensibly protects these vital organs from hypoxic-ischemic injury.

In our study blood count variables were found to be affected differently than observed by other authors. In the blood samples obtained on the 1st day of life, polyglobulia as a sign of chronic fetal hypoxia failed to be confirmed not even in a single case. After evaluation of red blood components in peripheral blood on the 1st day of life, we found a statistically significant decrease of erythrocytes and hemoglobin in asphyxial term newborns. Anemia required transfusion of erythrocytes in 4 newborns. We presumed that anemia was caused by intensification of oxidative stress during prenatal and direct postnatal period, as well as by blood redistribution or by hemorrhage. In 20 asphyxial term newborns we assumed the participation of adaptive mechanisms which help maintain optimal blood supply to the most sensitive organs (CNS, heart).

In asphyxia, in the first 96h of life increased peripheral leukocyte counts may contribute to abnormal neurodevelopmental outcome (Morkos et al., 2007). In our study we did not find any differences in leukocyte counts between HTN and ATN. During the first week of life the number of leukocytes decreased in both groups, indicating physiological changes normally seen in healthy term newborns. We can only assume that the asphyxia in our group of patients was of too short duration and low severity to produce changes observed by Morkos et al. (2007).

Thrombocytes take part in hemostasis, influence coagulation cascade and are the main source of many biologically active substances. Thrombocytopenia can be observed during the first 2 days of life, on the 10th day of life a normal number of thrombocytes is established.

In either groups studied we did not confirm a statistically significant thrombocytopenia, though in the group of asphyxial newborns the levels of thrombocytes were slightly decreased on 1st and 5th day of life. We agree with the finding of Phelan et al. (2007), that thrombocytopenia is inconsistent with acute birth asphyxia and therefore is not a sensitive marker in the case of a mild degree of acute asphyxia.


In spite of the recent decrease of perinatal morbidity and mortality, the risk of pre/postnatal CNS damage as a consequence of asphyxia did not decrease. The aim of current perinatology research is finding and determining the most sensitive, easily obtainable and fast assessable parameter of the presence and quantification of asphyxia.

The newborns have inadequate antioxidant protection and oxidative stress is a major cause of irreversible CNS damage in term asphyxial newborns. Studies have confirmed the helpful effects of antioxidant supplementation during hypoxemia (Pecháň et al., 1996; Holomáň & Pecháň, 2002; Holomáň et al., 1999; Vento et al., 2003; Shoji & Koletzko, 2007). Our results showed the presence of asphyxia of short duration to be without occurrence of polyglobulia as a sign of chronic hypoxia, and that by using simple blood tests commonly applied by neonatologists. Hematological changes observed early after delivery can determine the duration of hypoxemia (acute vs. chronic). These laboratory findings are often vital for neonatologist in case of unknown history of fetal asphyxia.

In combination with other biochemical blood parameters (Brucknerová et al., 2007; Farkouh et al., 2006) and clinical signs we may predict the severity of the asphyxial insult and decide on the relevant therapeutic strategy and management of newborns.


The study was supported by the grant from VEGA 2/0083/08.

Bracci R,Perrone S,Buonocore G. The timing of neonatal brain injuryBiol NeonateYear: 200690314515516582539
Brucknerová I,Benedeková M. Asphyxia of the newborn – the ever topical problemBiologiaYear: 20005582326
Brucknerová I,Benedeková M,Pecháň I,Holomáň K,Bieliková E,Kostrová A,Ujházy E,Dubovický M,Mach M. Delivery as a “physiological stress” and its influence on some parameters of oxidative stressNeuroendocrinol LettYear: 20072726568
Brucknerová I,Benedeková M,Pecháň I,Holomáň K,Bieliková E,Kostrová A,Ujházy E,Dubovický M. Delivery as a „physiological stress” and its influence on liver enzymatic systems in asphyxial newbornsBiomed PapersYear: 20051492409411
Curtin W-M,Shehata B-M,Khuder S-A,Robinson H-B,Brost B-C. The feasibility of using histologic placental sections to predict newborn nucleated red blood cell countsObstetrics and GynecologyYear: 200210030531012151154
Fahnenstich H,Dame C,Allera A,Rosskamo R,Kowalewski S. Erythropoetin as a biochemical parameter for fetal hypoxiaKlin pediatrYear: 1995207326330
Farkouh C-R,Merrill J-D,Ballard P-L,Ballard R-A,Ischiropoulos H,Lorch S-A. Urinary metabolites of oxidative stress and nitric oxide in preterm and term InfantsBiol NeonateYear: 20069023324216735789
Holomáň M,Pecháň I. The protection of myocardium in cardiovascular surgeryYear: 2002BratislavaELÁN ISBN 80-85331-33-0, 152 pp. [in Slovak].
Holomáň M,Záhorec R,Rendeková V,Pecháň I. Vitamin E for skeletal muscle protection against reperfusion injury during elective revascularization surgery (biochemical and clinical assessment)Cor et VasaYear: 1999417383
Morkos A-A,Hopper A-O,Deming D-D,Yellon S-M,Wycliffe N,Ashwal S,Sowers L-C,Peverini R-L,Angeles D-M. Elevated total peripheral leukocyte count may identify risk for neurological disability in asphyxiated term neonatesJ PerinatolYear: 20072763657017443199
Pecháň I,Holomáň M,Záhorec R,Rendeková V,Gabauer I. Antioxidant vitamins and phosphocreatine as protective agents in cardiac surgery. Biochemical parametersCor EuropYear: 199656973
Phelan J-P,Ahn M-O,Korst L-M,Martin G-I. Nucleated red blod cells: a marker of fetal asphyxia?Am J Obstet GynecolYear: 1995173138013847503172
Phelan J-P,Kirkendall C,Korst L-M,Martin G-I. Nucleated red blood cell and platelet counts in asphyxiated neonates sufficient to result in permanent neurologic impairmentJ Mater Fetal Neonatal MedYear: 200720537780
Rolfo A,Maconi M,Cardaropoli S,Biolcati M,Danise P,Todros T. Nucleated red blood cells in term fetuses: reference values using an automated analyzerNeonatologyYear: 20079220520817476121
Shoji H,Koletzko B. Oxidative stress and antioxidant protection in the perinatal periodCurr Opin Clin Nutr Metab CareYear: 200710332432817414502
Singer D. Neonatal tolerance to hypoxia: a comparative-physiological approachComparative Biochemistry and Physiology, Part AYear: 1999123221234
Tsukahara H. Biomarkers for oxidative stress: clinical application in pediatric medicineCurr Med ChemYear: 200714333935117305536
Vento M,Asensi M,Sastre J,Lloret A,Garcia-Sala F,Vina J. Oxidative stress in asphyxiated term infants resuscitated with 100% oxygenJ PediatricsYear: 2003142240246

[TableWrap ID: T0001] Table 1 

Blood count results.

Parameter 1st day of life 5th day of life

Term healthy newborns Term asphyxial newborns Term healthy newborns Term asphyxial newborns
(n=15) (n=24) (n=15) (n=24)
Leukocytes 19.61±1.44 18.83±1.66 11.82±1.57 10.27±1.10
Erythrocytes 5.22±0.14 4.38±0.12** 5.03±0.13 4.14±0.12***
Hemoglobin 187.13±5.88 160.66±5.4** 178.80±5.28 147.09±5.03***
Hematocrit 0.53±0.01 0.45±0.01** 0.50±0.01 0.41±0.01***
Thrombocytes 255.26±15.07 231.25±17.59 274.06±14.73 239.95±21.68

**p ≤ 0.01;

***p ≤ 0.001-statistically significant difference between both groups on the same day of life

Article Categories:
  • Original Article

Keywords: asphyxia, newborns, hemoglobin, erythrocyte, hematocrit, thrombocyte, leukocyte.

Previous Document:  Evaluation of developmental neurotoxicity: some important issues focused on neurobehavioral developm...
Next Document:  The effects of dithiaden on nitric oxide production by RAW 264.7 cells.